{"id":{"repo_id":"greece","oai_identifier":"oai:10442/1445"},"canonical_url":"https://search.dev.ndltd.org/etd/greece/oai:10442/1445","repository":{"repo_id":"greece","name":"Greek National Archive of PhD Theses","base_url":"https://phdtheses.ekt.gr/eadd_oai/request"},"display":{"title":"ΜΕΛΕΤΗ ΤΩΝ ΡΙΒΟΝΟΥΚΛΕΑΣΩΝ ΤΟΥ ΟΡΟΥ ΤΟΥ ΑΙΜΑΤΟΣ ΣΕ ΥΓΙΕΙΣ ΚΑΙ ΑΣΘΕΝΕΙΣ ΜΕ ΚΑΡΚΙΝΟ ΚΑΙ ΜΙΑΣ ΠΡΩΤΕΙΝΗΣ ΠΟΥ ΠΑΡΕΜΒΑΙΝΕΙ ΣΤΗ ΔΡΑΣΗ ΤΟΥΣ","abstract":"FIVE RIBONUCLEASES WERE PURIFIED FROM THE SERUM OF NORMAL HUMAN SUBJECTS. THE PROPERTIES OF FOUR OF THEM WERE IDENTICAL TO THOSE OF THE SECRETORY TYPE RIBONUCLEASES (OPTIMUM PH 8 AND FASTER HYDROLYSIS OF POLY-C COMPARED TO POLY-K). THE FIFTH ENZYME, WITH THE LOWER MOL. SIZE, HYDROLYZED FASTER POLY-K WITH AN OPTIMUMPH 7, AND THUS CAN BE CLASSIFIED TO THE NON-SECRETORY TYPE RIBONUCLEASES. THE SERUM RIBONUCLEASES OF PATIENTS WITH CANCER WERE IN GENERAL IDENTICAL WITH THOSE OF HEALTHY SUBJECTS EXCEPT FOR HEPATOMA PATIENTS WHERE THE FIFTH ENZYME WAS ALSO OF SECRETORY TYPE. A PROTEIN NAMED PRP 150 WITH MOL. SIZE 150 KD WAS PURIFIED TO HOMOGENEITY FROM HUMAN SERUM. PRP 150 IN THE PRESENCE OF RIBONUCLEASE PROTECTS RNA AGAINST ACID PRECIPITATION WITH TCA. THE PROTECTIVE ACTIVITY WAS MEASURED WITH POLY-U AS SUBSTRATE IN THE SERA OF HEALTHY INDIVIDUALS AND CANCER PATIENTS. A 2-5 FOLD INCREASE WAS OBSERVED IN THE LATTER. THE RESULTS OBTAINED, SHOWED THAT PRP 150 COULD BE A TRUSTWORTHY MARKER FOR THE DETECTION OF CANCER ANDTHE DIFFERENTIATION OF CANCER PATIENTS AND PATIENTS WITH NON-NEOPLASMIC DISEASES.","abstract_html":"FIVE RIBONUCLEASES WERE PURIFIED FROM THE SERUM OF NORMAL HUMAN SUBJECTS. THE PROPERTIES OF FOUR OF THEM WERE IDENTICAL TO THOSE OF THE SECRETORY TYPE RIBONUCLEASES (OPTIMUM PH 8 AND FASTER HYDROLYSIS OF POLY-C COMPARED TO POLY-K). THE FIFTH ENZYME, WITH THE LOWER MOL. SIZE, HYDROLYZED FASTER POLY-K WITH AN OPTIMUMPH 7, AND THUS CAN BE CLASSIFIED TO THE NON-SECRETORY TYPE RIBONUCLEASES. THE SERUM RIBONUCLEASES OF PATIENTS WITH CANCER WERE IN GENERAL IDENTICAL WITH THOSE OF HEALTHY SUBJECTS EXCEPT FOR HEPATOMA PATIENTS WHERE THE FIFTH ENZYME WAS ALSO OF SECRETORY TYPE. A PROTEIN NAMED PRP 150 WITH MOL. SIZE 150 KD WAS PURIFIED TO HOMOGENEITY FROM HUMAN SERUM. PRP 150 IN THE PRESENCE OF RIBONUCLEASE PROTECTS RNA AGAINST ACID PRECIPITATION WITH TCA. THE PROTECTIVE ACTIVITY WAS MEASURED WITH POLY-U AS SUBSTRATE IN THE SERA OF HEALTHY INDIVIDUALS AND CANCER PATIENTS. A 2-5 FOLD INCREASE WAS OBSERVED IN THE LATTER. THE RESULTS OBTAINED, SHOWED THAT PRP 150 COULD BE A TRUSTWORTHY MARKER FOR THE DETECTION OF CANCER ANDTHE DIFFERENTIATION OF CANCER PATIENTS AND PATIENTS WITH NON-NEOPLASMIC DISEASES.","abstract_has_math":false,"creators":["Kouretas, Dimitrios","Κουρέτας, Δημήτριος"],"institution":"Aristotle University Of Thessaloniki (AUTH)","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":1990,"date_issued":"1990","date_published":"1990","updated_at":"2026-07-24T02:24:56Z","subjects":["ΒΙΟΛΟΓΙΚΟΙ ΔΕΙΚΤΕΣ ΚΑΡΚΙΝΟΥ","Καρκίνος","ΟΡΟΣ ΑΙΜΑΤΟΣ ΑΝΘΡΩΠΟΥ","ΠΡΟΣΤΑΣΙΑ ΤΟΥ RNA ΑΠΟ ΟΞΙΝΗ ΚΑΤΑΒΥΘΙΣΗ","Ριβονουκλεάση","ACID PRECIPITATION OF RNA","Cancer","Human serum","Ribonuclease","Tumor markers","Φυσικές Επιστήμες","Χημεία","Natural Sciences","Chemical Sciences"],"languages":["gre"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/1445"],"render_values":[{"text":"10.12681/eadd/1445","href":"https://doi.org/10.12681/eadd/1445","code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/10442/hedi/1445","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Kouretas, Dimitrios","Κουρέτας, Δημήτριος"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["1990"]},{"key":"dc:publisher","label":"Institution","values":["Aristotle University Of Thessaloniki (AUTH)","Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)"]},{"key":"dc:type","label":"Dc Type","values":["PhD Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["ΒΙΟΛΟΓΙΚΟΙ ΔΕΙΚΤΕΣ ΚΑΡΚΙΝΟΥ","Καρκίνος","ΟΡΟΣ ΑΙΜΑΤΟΣ ΑΝΘΡΩΠΟΥ","ΠΡΟΣΤΑΣΙΑ ΤΟΥ RNA ΑΠΟ ΟΞΙΝΗ ΚΑΤΑΒΥΘΙΣΗ","Ριβονουκλεάση","ACID PRECIPITATION OF RNA","Cancer","Human serum","Ribonuclease","Tumor markers","Φυσικές Επιστήμες","Χημεία","Natural Sciences","Chemical Sciences"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["gre"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["10.12681/eadd/1445","http://hdl.handle.net/10442/hedi/1445"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["FIVE RIBONUCLEASES WERE PURIFIED FROM THE SERUM OF NORMAL HUMAN SUBJECTS. THE PROPERTIES OF FOUR OF THEM WERE IDENTICAL TO THOSE OF THE SECRETORY TYPE RIBONUCLEASES (OPTIMUM PH 8 AND FASTER HYDROLYSIS OF POLY-C COMPARED TO POLY-K). THE FIFTH ENZYME, WITH THE LOWER MOL. SIZE, HYDROLYZED FASTER POLY-K WITH AN OPTIMUMPH 7, AND THUS CAN BE CLASSIFIED TO THE NON-SECRETORY TYPE RIBONUCLEASES. THE SERUM RIBONUCLEASES OF PATIENTS WITH CANCER WERE IN GENERAL IDENTICAL WITH THOSE OF HEALTHY SUBJECTS EXCEPT FOR HEPATOMA PATIENTS WHERE THE FIFTH ENZYME WAS ALSO OF SECRETORY TYPE. A PROTEIN NAMED PRP 150 WITH MOL. SIZE 150 KD WAS PURIFIED TO HOMOGENEITY FROM HUMAN SERUM. PRP 150 IN THE PRESENCE OF RIBONUCLEASE PROTECTS RNA AGAINST ACID PRECIPITATION WITH TCA. THE PROTECTIVE ACTIVITY WAS MEASURED WITH POLY-U AS SUBSTRATE IN THE SERA OF HEALTHY INDIVIDUALS AND CANCER PATIENTS. A 2-5 FOLD INCREASE WAS OBSERVED IN THE LATTER. THE RESULTS OBTAINED, SHOWED THAT PRP 150 COULD BE A TRUSTWORTHY MARKER FOR THE DETECTION OF CANCER ANDTHE DIFFERENTIATION OF CANCER PATIENTS AND PATIENTS WITH NON-NEOPLASMIC DISEASES.","ΑΠΟ ΤΟ ΟΡΟ ΑΙΜΑΤΟΣ ΥΓΙΩΝ ΑΤΟΜΩΝ ΚΑΘΟΡΙΣΤΗΚΑΝ ΠΕΝΤΕ ΡΙΒΟΝΟΥΚΛΕΑΣΕΣ ΑΠΟ ΤΙΣ ΟΠΟΙΕΣ ΟΙ ΤΕΣΣΕΡΙΣ ΛΟΓΩ ΤΩΝ ΙΔΙΟΤΗΤΩΝ ΤΟΥΣ (ΒΕΛΤΙΣΤΟ PH 8, ΥΔΡΟΛΥΣΗ ΤΟΥ POLY-C ΤΑΧΥΤΕΡΑ ΑΠΟ ΤΟ POLY-K) ΑΝΗΚΟΥΝ ΣΤΙΣ ΕΚΚΡΙΤΙΚΟΥ ΤΥΠΟΥ, ΕΝΩ Η ΠΕΜΠΤΗ ΚΑΙ ΜΙΚΡΟΤΕΡΗ ΣΕΜ.Β. ΠΟΥ ΥΔΡΟΛΥΕΙ ΤΑΧΥΤΕΡΑ ΤΟ POLY-K ΚΑΙ ΕΧΕΙ ΒΕΛΤΙΣΤΟ PH 7 ΑΝΗΚΕΙ ΣΤΙΣ ΜΗ ΕΚΚΡΙΤΙΚΟΥ ΤΥΠΟΥ. ΣΤΟΥΣ ΑΣΘΕΝΕΙΣ ΜΕ ΚΑΡΚΙΝΟ ΕΝΤΟΠΙΣΤΗΚΑΝ ΓΕΝΙΚΑ ΤΑ ΙΔΙΑ ΕΝΖΥΜΑ. ΜΟΝΟ ΣΤΟΝ ΚΑΡΚΙΝΟ ΤΟΥ ΗΠΑΤΟΣ ΠΑΡΑΤΗΡΗΘΗΚΑΝ ΔΙΑΦΟΡΕΣ ΚΑΙ ΣΥΓΚΕΚΡΙΜΕΝΑ ΣΤΗ ΘΕΣΗ ΤΟΥΠΕΜΠΤΟΥ ΕΝΖΥΜΟΥ ΤΟΥ ΟΡΟΥ ΥΓΙΩΝ, ΥΠΗΡΧΕ ΜΙΑ ΡΙΒΟΝΟΥΚΛΕΑΣΗ ΠΟΥ ΕΜΟΙΑΖΕ ΩΣ ΠΡΟΣ ΤΙΣ ΙΔΙΟΤΗΤΕΣ ΣΤΑ ΕΝΖΥΜΑ ΕΚΚΡΙΤΙΚΟΥ ΤΥΠΟΥ. Η ΡΙΒΟΝΟΥΚΛΕΑΣΗ ΑΥΤΗ ΕΛΕΙΠΕ ΑΠΟ ΤΟΝ ΟΡΟ ΥΓΙΩΝ. ΑΠΟ ΤΟΝ ΟΡΟ ΕΠΙΣΗΣ ΚΑΘΑΡΙΣΤΗΚΕ ΜΙΑ ΠΡΩΤΕΙΝΗ ΜΟΡΙΑΚΟΥ ΒΑΡΟΥΣ 150 KD ΗΟΠΟΙΑ ΣΕ ΣΥΝΕΡΓΑΣΙΑ ΜΕ ΤΗ ΡΙΒΟΝΟΥΚΛΕΑΣΗ ΠΡΟΣΤΑΤΕΥΕ ΤΑ ΡΙΒΟΝΟΥΚΛΕΙΝΙΚΑ ΟΞΕΑ ΑΠΟΟΞΙΝΗ ΚΑΤΑΒΥΘΙΣΗ ΣΕ ΔΙΑΛΥΜΑ TCA. Η ΠΡΩΤΕΙΝΗ ΑΥΤΗ ΜΕΤΡΗΘΗΚΕ ΣΕ ΠΟΛΛΟΥΣ ΟΡΟΥΣ ΑΣΘΕΝΩΝ ΜΕ ΚΑΡΚΙΝΟ ΚΑΘΩΣ ΚΑΙ ΥΓΙΩΝ (ΜΕ ΥΠΟΣΤΡΩΜΑ POLY-K) ΚΑΙ ΔΙΑΠΙΣΤΩΘΗΚΕ ΟΤΙ ΑΥΞΑΝΕΤΑΙ ΣΗΜΑΝΤΙΚΑ ΣΤΟΝ ΟΡΟ ΤΩΝ ΠΕΡΙΣΣΟΤΕΡΩΝ ΑΣΘΕΝΩΝ ΜΕ ΚΑΡΚΙΝΟ. ΤΑ ΣΤΟΙΧΕΙΑ ΠΟΥ ΣΥΛΛΕΧΘΗΚΑΝ ΔΕΙΧΝΟΥΝ ΟΤΙ Η ΠΡΩΤΕΙΝΗ ΑΥΤΗ ΘΑ ΜΠΟΡΟΥΣΕ ΝΑ ΑΠΟΤΕΛΕΣΕΙ ΑΞΙΟΠΙΣΤΟ ΔΕΙΚΤΗ ΓΙΑ ΤΗ ΔΙΑΚΡΙΣΗ ΤΩΝ ΚΑΡΚΙΝΟΠΑΘΩΝ ΟΧΙ ΜΟΝΟ ΑΠΟ ΤΟΥΣ ΥΓΙΕΙΣ ΑΛΛΑ ΚΑΙ ΑΠΟ ΤΟΥΣ ΑΣΘΕΝΕΙΣ ΜΕ ΜΗ ΝΕΟΠΛΑΣΤΙΚΕΣ ΝΟΣΟΥΣ."]},{"key":"dc:title","label":"Title","values":["ΜΕΛΕΤΗ ΤΩΝ ΡΙΒΟΝΟΥΚΛΕΑΣΩΝ ΤΟΥ ΟΡΟΥ ΤΟΥ ΑΙΜΑΤΟΣ ΣΕ ΥΓΙΕΙΣ ΚΑΙ ΑΣΘΕΝΕΙΣ ΜΕ ΚΑΡΚΙΝΟ ΚΑΙ ΜΙΑΣ ΠΡΩΤΕΙΝΗΣ ΠΟΥ ΠΑΡΕΜΒΑΙΝΕΙ ΣΤΗ ΔΡΑΣΗ ΤΟΥΣ","STUDY OF RIBONUCLEASES IN THE SERUM OF HEALTHY INDIVIDUALS AND CANCER PATIENTS AS WELL AS OF ONE PROTEIN WHICH INTERFERES WITH THEIR ACTION"]}]}],"canonical_facts":{"dc:creator":["Kouretas, Dimitrios","Κουρέτας, Δημήτριος"],"dc:date":["1990"],"dc:description":["FIVE RIBONUCLEASES WERE PURIFIED FROM THE SERUM OF NORMAL HUMAN SUBJECTS. THE PROPERTIES OF FOUR OF THEM WERE IDENTICAL TO THOSE OF THE SECRETORY TYPE RIBONUCLEASES (OPTIMUM PH 8 AND FASTER HYDROLYSIS OF POLY-C COMPARED TO POLY-K). THE FIFTH ENZYME, WITH THE LOWER MOL. SIZE, HYDROLYZED FASTER POLY-K WITH AN OPTIMUMPH 7, AND THUS CAN BE CLASSIFIED TO THE NON-SECRETORY TYPE RIBONUCLEASES. THE SERUM RIBONUCLEASES OF PATIENTS WITH CANCER WERE IN GENERAL IDENTICAL WITH THOSE OF HEALTHY SUBJECTS EXCEPT FOR HEPATOMA PATIENTS WHERE THE FIFTH ENZYME WAS ALSO OF SECRETORY TYPE. A PROTEIN NAMED PRP 150 WITH MOL. SIZE 150 KD WAS PURIFIED TO HOMOGENEITY FROM HUMAN SERUM. PRP 150 IN THE PRESENCE OF RIBONUCLEASE PROTECTS RNA AGAINST ACID PRECIPITATION WITH TCA. THE PROTECTIVE ACTIVITY WAS MEASURED WITH POLY-U AS SUBSTRATE IN THE SERA OF HEALTHY INDIVIDUALS AND CANCER PATIENTS. A 2-5 FOLD INCREASE WAS OBSERVED IN THE LATTER. THE RESULTS OBTAINED, SHOWED THAT PRP 150 COULD BE A TRUSTWORTHY MARKER FOR THE DETECTION OF CANCER ANDTHE DIFFERENTIATION OF CANCER PATIENTS AND PATIENTS WITH NON-NEOPLASMIC DISEASES.","ΑΠΟ ΤΟ ΟΡΟ ΑΙΜΑΤΟΣ ΥΓΙΩΝ ΑΤΟΜΩΝ ΚΑΘΟΡΙΣΤΗΚΑΝ ΠΕΝΤΕ ΡΙΒΟΝΟΥΚΛΕΑΣΕΣ ΑΠΟ ΤΙΣ ΟΠΟΙΕΣ ΟΙ ΤΕΣΣΕΡΙΣ ΛΟΓΩ ΤΩΝ ΙΔΙΟΤΗΤΩΝ ΤΟΥΣ (ΒΕΛΤΙΣΤΟ PH 8, ΥΔΡΟΛΥΣΗ ΤΟΥ POLY-C ΤΑΧΥΤΕΡΑ ΑΠΟ ΤΟ POLY-K) ΑΝΗΚΟΥΝ ΣΤΙΣ ΕΚΚΡΙΤΙΚΟΥ ΤΥΠΟΥ, ΕΝΩ Η ΠΕΜΠΤΗ ΚΑΙ ΜΙΚΡΟΤΕΡΗ ΣΕΜ.Β. ΠΟΥ ΥΔΡΟΛΥΕΙ ΤΑΧΥΤΕΡΑ ΤΟ POLY-K ΚΑΙ ΕΧΕΙ ΒΕΛΤΙΣΤΟ PH 7 ΑΝΗΚΕΙ ΣΤΙΣ ΜΗ ΕΚΚΡΙΤΙΚΟΥ ΤΥΠΟΥ. ΣΤΟΥΣ ΑΣΘΕΝΕΙΣ ΜΕ ΚΑΡΚΙΝΟ ΕΝΤΟΠΙΣΤΗΚΑΝ ΓΕΝΙΚΑ ΤΑ ΙΔΙΑ ΕΝΖΥΜΑ. ΜΟΝΟ ΣΤΟΝ ΚΑΡΚΙΝΟ ΤΟΥ ΗΠΑΤΟΣ ΠΑΡΑΤΗΡΗΘΗΚΑΝ ΔΙΑΦΟΡΕΣ ΚΑΙ ΣΥΓΚΕΚΡΙΜΕΝΑ ΣΤΗ ΘΕΣΗ ΤΟΥΠΕΜΠΤΟΥ ΕΝΖΥΜΟΥ ΤΟΥ ΟΡΟΥ ΥΓΙΩΝ, ΥΠΗΡΧΕ ΜΙΑ ΡΙΒΟΝΟΥΚΛΕΑΣΗ ΠΟΥ ΕΜΟΙΑΖΕ ΩΣ ΠΡΟΣ ΤΙΣ ΙΔΙΟΤΗΤΕΣ ΣΤΑ ΕΝΖΥΜΑ ΕΚΚΡΙΤΙΚΟΥ ΤΥΠΟΥ. Η ΡΙΒΟΝΟΥΚΛΕΑΣΗ ΑΥΤΗ ΕΛΕΙΠΕ ΑΠΟ ΤΟΝ ΟΡΟ ΥΓΙΩΝ. ΑΠΟ ΤΟΝ ΟΡΟ ΕΠΙΣΗΣ ΚΑΘΑΡΙΣΤΗΚΕ ΜΙΑ ΠΡΩΤΕΙΝΗ ΜΟΡΙΑΚΟΥ ΒΑΡΟΥΣ 150 KD ΗΟΠΟΙΑ ΣΕ ΣΥΝΕΡΓΑΣΙΑ ΜΕ ΤΗ ΡΙΒΟΝΟΥΚΛΕΑΣΗ ΠΡΟΣΤΑΤΕΥΕ ΤΑ ΡΙΒΟΝΟΥΚΛΕΙΝΙΚΑ ΟΞΕΑ ΑΠΟΟΞΙΝΗ ΚΑΤΑΒΥΘΙΣΗ ΣΕ ΔΙΑΛΥΜΑ TCA. Η ΠΡΩΤΕΙΝΗ ΑΥΤΗ ΜΕΤΡΗΘΗΚΕ ΣΕ ΠΟΛΛΟΥΣ ΟΡΟΥΣ ΑΣΘΕΝΩΝ ΜΕ ΚΑΡΚΙΝΟ ΚΑΘΩΣ ΚΑΙ ΥΓΙΩΝ (ΜΕ ΥΠΟΣΤΡΩΜΑ POLY-K) ΚΑΙ ΔΙΑΠΙΣΤΩΘΗΚΕ ΟΤΙ ΑΥΞΑΝΕΤΑΙ ΣΗΜΑΝΤΙΚΑ ΣΤΟΝ ΟΡΟ ΤΩΝ ΠΕΡΙΣΣΟΤΕΡΩΝ ΑΣΘΕΝΩΝ ΜΕ ΚΑΡΚΙΝΟ. ΤΑ ΣΤΟΙΧΕΙΑ ΠΟΥ ΣΥΛΛΕΧΘΗΚΑΝ ΔΕΙΧΝΟΥΝ ΟΤΙ Η ΠΡΩΤΕΙΝΗ ΑΥΤΗ ΘΑ ΜΠΟΡΟΥΣΕ ΝΑ ΑΠΟΤΕΛΕΣΕΙ ΑΞΙΟΠΙΣΤΟ ΔΕΙΚΤΗ ΓΙΑ ΤΗ ΔΙΑΚΡΙΣΗ ΤΩΝ ΚΑΡΚΙΝΟΠΑΘΩΝ ΟΧΙ ΜΟΝΟ ΑΠΟ ΤΟΥΣ ΥΓΙΕΙΣ ΑΛΛΑ ΚΑΙ ΑΠΟ ΤΟΥΣ ΑΣΘΕΝΕΙΣ ΜΕ ΜΗ ΝΕΟΠΛΑΣΤΙΚΕΣ ΝΟΣΟΥΣ."],"dc:identifier":["10.12681/eadd/1445","http://hdl.handle.net/10442/hedi/1445"],"dc:language":["gre"],"dc:publisher":["Aristotle University Of Thessaloniki (AUTH)","Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)"],"dc:subject":["ΒΙΟΛΟΓΙΚΟΙ ΔΕΙΚΤΕΣ ΚΑΡΚΙΝΟΥ","Καρκίνος","ΟΡΟΣ ΑΙΜΑΤΟΣ ΑΝΘΡΩΠΟΥ","ΠΡΟΣΤΑΣΙΑ ΤΟΥ RNA ΑΠΟ ΟΞΙΝΗ ΚΑΤΑΒΥΘΙΣΗ","Ριβονουκλεάση","ACID PRECIPITATION OF RNA","Cancer","Human serum","Ribonuclease","Tumor markers","Φυσικές Επιστήμες","Χημεία","Natural Sciences","Chemical Sciences"],"dc:title":["ΜΕΛΕΤΗ ΤΩΝ ΡΙΒΟΝΟΥΚΛΕΑΣΩΝ ΤΟΥ ΟΡΟΥ ΤΟΥ ΑΙΜΑΤΟΣ ΣΕ ΥΓΙΕΙΣ ΚΑΙ ΑΣΘΕΝΕΙΣ ΜΕ ΚΑΡΚΙΝΟ ΚΑΙ ΜΙΑΣ ΠΡΩΤΕΙΝΗΣ ΠΟΥ ΠΑΡΕΜΒΑΙΝΕΙ ΣΤΗ ΔΡΑΣΗ ΤΟΥΣ","STUDY OF RIBONUCLEASES IN THE SERUM OF HEALTHY INDIVIDUALS AND CANCER PATIENTS AS WELL AS OF ONE PROTEIN WHICH INTERFERES WITH THEIR ACTION"],"dc:type":["PhD Thesis"]},"updated_at":"2026-07-24T02:24:56Z"}